PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-55.23%
Negative net income growth while TSM stands at 4.83%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.30%
D&A growth well above TSM's 1.14%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
71.70%
Deferred tax of 71.70% while TSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-6.63%
Negative yoy SBC while TSM is 100.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-94.40%
Both reduce yoy usage, with TSM at -113.49%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
1192.19%
AR growth while TSM is negative at -129.53%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
340.24%
Some inventory rise while TSM is negative at -935.10%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-38.96%
Both negative yoy AP, with TSM at -44.70%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-131.42%
Negative yoy usage while TSM is 18.72%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
85.39%
Lower 'other non-cash' growth vs. TSM's 185.59%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-61.05%
Both yoy CFO lines are negative, with TSM at -7.70%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-37.50%
Both yoy lines negative, with TSM at -55.42%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
16.51%
Purchases well above TSM's 22.33%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-31.87%
We reduce yoy sales while TSM is 16.89%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-768.20%
Both yoy lines negative, with TSM at -165.51%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-63.17%
Both yoy lines negative, with TSM at -54.34%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-9.30%
We cut debt repayment yoy while TSM is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while TSM is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.